An earlier study (companion to PMID 14552529) showing Selank improves active avoidance learning in poor-learner rats and compares favorably to piracetam. Confirms dose-dependent cognitive enhancement with maximum effect on day 3 of training. The consistent replication of learning improvement across multiple studies establishes the cognitive-enhancing evidence base for Selank.
Kozlovskiĭ, I I; Danchev, N D